Platelet factor Xa receptor.
The assembly and function of the prothrombinase complex on the bovine and human platelet membrane is mediated through binding interactions in which factor Va bound to the platelet surface forms at least part of the "receptor" for factor Xa in a 1:1 stoichiometric complex. A model depicting these binding interactions is shown in Fig. 12. Data from our laboratory indicate that the prothrombinase catalyst assembles in an analogous manner on the surface of monocytes, lymphocytes, neutrophils, and well-defined phospholipid vesicles employed in model systems. The 74,000-Da subunit of factor Va, component E, which mediates the binding of factor Va to either bovine platelets, human monocytes, or phospholipid vesicles, is shown binding to the cell membrane through its putative "receptor." The 94,000-Da subunit of factor Va, component D, is associated with the membrane surface through its metal ion-dependent interaction with component E. Factor Va forms at least part of the receptor that mediates the binding of factor Xa to an appropriate membrane surface, because component E has been shown to contribute significantly to the interaction of factor Xa with either the platelet, monocyte, or vesicle membrane surface. Our data do not preclude the possibility that component D contributes to the binding of factor Xa and the function of the prothrombinase complex. Component D appears to be important for several reasons. Cleavage of component D by activated protein C results in the complete loss of factor Va cofactor activity. An interaction between factor Xa and component D is implied from the observation that factor Xa protects factor Va from activated protein C inactivation. Furthermore, the binding of factor Xa to platelet-bound factor Va results in the time-dependent cleavage of components D and D'. Because component D is not required absolutely for prothrombinase complex assembly, we would speculate that it may be important in mediating prothrombin binding (depicted as a three-domain molecule) and increasing the catalytic efficiency of the enzymatic complex.(ABSTRACT TRUNCATED AT 400 WORDS)
Tracy
P B
PB
Department of Biochemistry, University of Vermont College of Medicine, Burlington 05405.
Nesheim
M E
ME
Mann
K G
KG
D000818:Animals; D001792:Blood Platelets / Q000378:metabolism*; D002417:Cattle; D002462:Cell Membrane / Q000378:metabolism / Q000648:ultrastructure; D015943:Factor Va / Q000378:metabolism*; D015951:Factor Xa / Q000378:metabolism*; D006801:Humans; D007457:Iodine Radioisotopes; D007700:Kinetics; D046911:Macromolecular Substances; D008433:Mathematics; D008961:Models, Structural; D010980:Platelet Membrane Glycoproteins; D011516:Prothrombin / Q000378:metabolism; D011865:Radioisotope Dilution Technique; D011956:Receptors, Cell Surface / Q000302:isolation & purification / Q000378:metabolism*; D013925:Thromboplastin / Q000378:metabolism
D007457:Iodine Radioisotopes; D046911:Macromolecular Substances; D010980:Platelet Membrane Glycoproteins; D011956:Receptors, Cell Surface; C045069:factor X receptors; D015943:Factor Va; D011516:Prothrombin; D013925:Thromboplastin; D015951:Factor Xa